|
| |||||
|
STAFF BIOGRAPHIES
Sheldon J. Segal, Ph.D.
Distinguished Scientist
What's New
The Council and Sheldon J. Segal have been awarded the 2008 Prix Galien USA Pro Bono Humanum
Award. Both the Council and Segal were
recognized for their role in developing contraceptive implantable hormone
delivery systems. (more)
Segal recently received the Society of Family Planning's Lifetime
Achievement Award. The society created this award to recognize
outstanding individuals whose cumulative research has reached the highest
level of importance in the field. (more) Sheldon J.
Segal is Distinguished Scientist at the Population Council and
chairman of the Council's Institutional Review Board. He is the former
director for Population Sciences at the Rockefeller Foundation and
continues his association with the Foundation as the Ella Walker
Distinguished Scholar, Bellagio Study Center. He is an adjunct professor
of clinical pharmacology at Cornell Medical School. A leading authority
on global population issues, family planning, and contraceptive
technology, Segal is a member of the National Academy of Sciences'
Institute of Medicine and is the 1984 Laureate of the United Nations
Population Award. He has served as advisor to the World Health
Organization and to the United Nations Population Fund, the World Bank,
the European Parliament, and the US Congress. He is the author of over
300 publications in the field of embryology, endocrinology, the biology of
reproduction, contraceptive development, and family planning, and has
served on the editorial boards of six scientific journals. Segal received
his B.A. at Dartmouth and holds a Ph.D. in embryology and biochemistry
from the University of Iowa, in addition to three honorary doctorates. In
2007, he was awarded the Joseph Bolivar DeLee Humanitarian Award,
conferred by the University of Chicago for an "extraordinary
contribution to the health of women and infants." Segal directed the
research that led to the development of copper-bearing IUDs and implant
contraceptives (Jadelle® and Norplant®), as well as
initial studies on contraceptive vaginal rings, the intrauterine system Mirena®, contraceptive vaccines, and male contraceptives. The
modern IUD and Norplant provide contraception for more than 120 million
women globally. |
|||||